T regulatory lymphocytes (Treg) maintain immune tolerance by suppressing both innate and adaptive immune cells. Tregs are atheroprotective, yet Treg phenotypes and function are disturbed during atherosclerosis progression. High-density lipoproteins (HDL) are atheroprotective, in large part due to their function in reverse cholesterol transport. However, HDL also performs cholesterol-independent functions, including the transport of sphingosine-1-phosphate (S1P), an important lipid mediator of immunity. Apolipoprotein M, found on HDL, binds S1P to aid in delivery of S1P to cells in the vasculature, including cells involved in adaptive immunity. Based upon our work and that of others, S1P most likely acts to impart differential effects on cytokine production by dendritic cells and lymphocyte depending on the microenvironment. We hypothesize that a novel function of HDL in adaptive immunity is related to the ability of HDL to stabilize Treg homeostasis and suppressive activity in vivo during atherogenesis. We will test our hypotheses in 2 specific aims.
Specific Aim 1 will test the hypothesis that HDL regulates Treg homeostasis in atherosclerosis through S1P action.
Specific Aim 2 will identify mechanisms for how HDL-S1P impacts both cell-autonomous dendritic cell and Treg actions to preserve Treg function in atherosclerosis.

Public Health Relevance

T regulatory lymphocytes (Treg) suppress both innate and adaptive immune cells, and are atheroprotective. High-density lipoproteins (HDL) transport sphingosine-1- phosphate (S1P) in circulation. S1P is an important lipid mediator in immunity. We hypothesize that HDL, through delivery of S1P to immune cells, plays a novel role in adaptive immunity through preservation of Treg homeostasis and suppressive activity in vivo during atherogenesis.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01HL112276-02
Application #
8666802
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Liu, Lijuan
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Sorci-Thomas, Mary G; Thomas, Michael J (2016) Microdomains, Inflammation, and Atherosclerosis. Circ Res 118:679-91
Cheng, Hsin-Yuan; Gaddis, Dalia E; Wu, Runpei et al. (2016) Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest 126:3236-46
Navratil, Aaron R; Vozenilek, Aimee E; Cardelli, James A et al. (2015) Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses. Atherosclerosis 242:424-32
Sorci-Thomas, Mary G; Pollard, Ricquita D; Thomas, Michael J (2015) What does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport? Curr Opin Lipidol 26:420-5
Thomas, Michael J; Sorci-Thomas, Mary G (2015) SAA: a link between cholesterol efflux capacity and inflammation? J Lipid Res 56:1383-5
Pollard, Ricquita D; Blesso, Christopher N; Zabalawi, Manal et al. (2015) Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake. J Biol Chem 290:15496-511
Gerhardt, Teresa; Ley, Klaus (2015) Monocyte trafficking across the vessel wall. Cardiovasc Res 107:321-30
Hedrick, Catherine C (2015) Lymphocytes in atherosclerosis. Arterioscler Thromb Vasc Biol 35:253-7
Chadwick, Alexandra C; Holme, Rebecca L; Chen, Yiliang et al. (2015) Acrolein impairs the cholesterol transport functions of high density lipoproteins. PLoS One 10:e0123138
Liu, Jing; Lu, Hong; Howatt, Deborah A et al. (2015) Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 35:1826-34

Showing the most recent 10 out of 13 publications